X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10199) 10199
Magazine Article (81) 81
Book Chapter (35) 35
Dissertation (13) 13
Publication (11) 11
Book / eBook (9) 9
Newsletter (4) 4
Reference (3) 3
Government Document (2) 2
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8155) 8155
male (3574) 3574
female (3502) 3502
polycythemia-vera (3498) 3498
hematology (3276) 3276
middle aged (3122) 3122
polycythemia vera (2886) 2886
aged (2666) 2666
essential thrombocythemia (2467) 2467
adult (2353) 2353
mutation (1703) 1703
oncology (1451) 1451
polycythemia vera - complications (1442) 1442
janus kinase 2 - genetics (1427) 1427
myelofibrosis (1281) 1281
myeloproliferative disorders (1277) 1277
polycythemia vera - blood (1057) 1057
aged, 80 and over (1010) 1010
polycythemia vera - genetics (1004) 1004
tyrosine kinase jak2 (973) 973
polycythemia vera - diagnosis (957) 957
myeloproliferative neoplasms (937) 937
leukemia (880) 880
polycythemia (813) 813
polycythemia vera - drug therapy (804) 804
myeloproliferative disorders - genetics (792) 792
polycythemia vera - pathology (783) 783
thrombosis (758) 758
jak2 (752) 752
polycythemia vera - therapy (752) 752
animals (726) 726
primary myelofibrosis (669) 669
diagnosis (657) 657
risk factors (620) 620
prognosis (587) 587
adolescent (583) 583
hydroxyurea (564) 564
medicine, general & internal (561) 561
thrombocythemia, essential - genetics (538) 538
diagnosis, differential (526) 526
primary myelofibrosis - genetics (492) 492
tumors (484) 484
hemic and lymphatic diseases (477) 477
myeloid metaplasia (473) 473
genetic aspects (440) 440
bone marrow - pathology (439) 439
janus kinase 2 (434) 434
mice (415) 415
disorders (403) 403
abridged index medicus (394) 394
hematocrit (385) 385
retrospective studies (384) 384
care and treatment (379) 379
therapy (379) 379
hydroxyurea - therapeutic use (375) 375
myeloproliferative disorders - diagnosis (375) 375
myeloproliferative disorders - pathology (373) 373
research (373) 373
primary myelofibrosis - pathology (368) 368
treatment outcome (364) 364
disease (355) 355
analysis (348) 348
janus kinase 2 - metabolism (347) 347
cancer (346) 346
pathology (342) 342
bone marrow (339) 339
follow-up studies (333) 333
thrombocythemia, essential - diagnosis (332) 332
expression (330) 330
risk (330) 330
young adult (330) 330
chronic myeloproliferative disorders (329) 329
thrombocythemia, essential - complications (326) 326
medicine & public health (323) 323
child (318) 318
chronic disease (316) 316
thrombocythemia, essential - drug therapy (311) 311
platelet count (302) 302
primary myelofibrosis - diagnosis (300) 300
survival (298) 298
activating mutation (296) 296
jak2 v617f mutation (291) 291
thrombosis - etiology (291) 291
antineoplastic agents - therapeutic use (288) 288
thrombocythemia, essential - pathology (286) 286
ruxolitinib (283) 283
polycythemia vera - physiopathology (281) 281
neoplasms (276) 276
acute myeloid-leukemia (275) 275
janus kinase 2 - antagonists & inhibitors (274) 274
anemia (271) 271
signal transduction (271) 271
erythropoietin (268) 268
hematology, oncology and palliative medicine (264) 264
medicine, research & experimental (262) 262
myeloproliferative disorders - drug therapy (262) 262
disease progression (259) 259
health aspects (259) 259
primary myelofibrosis - drug therapy (258) 258
myeloproliferative neoplasm (253) 253
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8445) 8445
German (487) 487
French (395) 395
Russian (307) 307
Italian (179) 179
Japanese (170) 170
Spanish (126) 126
Polish (96) 96
Hungarian (66) 66
Chinese (42) 42
Portuguese (39) 39
Korean (34) 34
Romanian (31) 31
Czech (28) 28
Danish (24) 24
Dutch (20) 20
Turkish (17) 17
Swedish (16) 16
Hebrew (10) 10
Norwegian (10) 10
Slovak (9) 9
Serbian (8) 8
Finnish (6) 6
Bulgarian (4) 4
Ukrainian (4) 4
Croatian (3) 3
Slovenian (3) 3
Afrikaans (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 1, pp. 22 - 33
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 7, pp. 601 - 612
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 22, pp. 2168 - 2181
Journal Article
Best Practice & Research: Clinical Haematology, ISSN 1521-6926, 2014, Volume 27, Issue 2, pp. 141 - 153
Polycythemia vera, essential thrombocythemia, and primary myleofibrosis are chronic myeloproliferative neoplasms (MPNs) associated with an increased morbidity... 
Hematology, Oncology and Palliative Medicine | leukemic transformation | leukemia etiology | antineoplastic agents | primary myelofibrosis | risk factor | alkylators | JAK2 mutation | hydroxyurea | polycythemia vera | essential thrombocythemia | radioactive phosphorous | myeloproliferative neoplasm | X-ray treatment | Primary myelofibrosis | Leukemia etiology | Alkylators | Hydroxyurea | Polycythemia vera | Antineoplastic agents | Radioactive phosphorous | Essential thrombocythemia | Risk factor | Leukemic transformation | Myeloproliferative neoplasm | PROGNOSTIC SCORING SYSTEM | POLYCYTHEMIA-VERA | BLAST-PHASE | ACUTE MYELOID-LEUKEMIA | INTERNATIONAL WORKING GROUP | CYTOGENETIC ABNORMALITIES | TYROSINE KINASE JAK2 | TERM-FOLLOW-UP | HEMATOLOGY | Primary Myelofibrosis - mortality | Humans | Polycythemia Vera - genetics | Antineoplastic Agents - therapeutic use | Leukemia, Myeloid, Acute - etiology | Thrombocythemia, Essential - genetics | Polycythemia Vera - mortality | Polycythemia Vera - complications | Leukemia, Myeloid, Acute - drug therapy | Myelodysplastic Syndromes - drug therapy | Thrombocythemia, Essential - drug therapy | Primary Myelofibrosis - drug therapy | Primary Myelofibrosis - complications | Janus Kinase 2 - genetics | Disease Progression | Myelodysplastic Syndromes - etiology | Leukemia, Myeloid, Acute - mortality | Primary Myelofibrosis - genetics | Thrombocythemia, Essential - mortality | Myelodysplastic Syndromes - mortality | Survival Analysis | Hydroxyurea - therapeutic use | Polycythemia Vera - drug therapy | Myelodysplastic Syndromes - genetics | Cell Transformation, Neoplastic - drug effects | Mutation | Cell Transformation, Neoplastic - pathology | Phosphorus Radioisotopes - therapeutic use | Leukemia, Myeloid, Acute - genetics | Thrombocythemia, Essential - complications | Leukemia
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 07/2010, Volume 104, Issue 1, pp. 151 - 156
Journal Article